In reply to:

In practice we still expect to be bought as a going concern, and D&M are as much in the running as any other potential purchaser.


That's good. I wasn't sure how it was going to be done (the whole thing at once, individual products, etc., and especially could legacy products like empeg be sold separately, as they've never been in production at SB).

As for pricing, I was recently (a couple of years ago) involved in a dot-bomb that ran through like 15 million dollars in two years, and sold for less than my house. So, from that experience, rights to one or another individual product might have been cheap.

At any rate, I've got my fingers crossed for all of you!!